Valuation: Zimmer Biomet Holdings, Inc.

Capitalization 21.5B 20.35B 18.86B 16.87B 30.4B 1,821B 33.65B 235B 86.77B 748B 80.77B 78.98B 3,224B P/E ratio 2024 *
22.2x
P/E ratio 2025 * 19x
Enterprise value 26.62B 25.19B 23.35B 20.88B 37.64B 2,254B 41.66B 291B 107B 926B 100B 97.78B 3,991B EV / Sales 2024 *
3.47x
EV / Sales 2025 * 3.12x
Free-Float
-
Yield 2024 *
0.89%
Yield 2025 * 0.91%
More valuation ratios * Estimated data
Dynamic Chart
1 day-1.04%
1 week-3.63%
Current month-3.63%
1 month-0.14%
3 months+3.07%
6 months-4.69%
Current year-11.23%
More quotes
1 week
107.71
Extreme 107.71
111.98
1 month
107.71
Extreme 107.71
114.72
Current year
101.47
Extreme 101.47
133.90
1 year
101.47
Extreme 101.47
133.90
3 years
100.39
Extreme 100.39
149.25
5 years
74.37
Extreme 74.37
180.36
10 years
74.37
Extreme 74.37
180.36
More quotes
Director TitleAgeSince
Chief Executive Officer 49 2023-08-21
Director of Finance/CFO 55 2019-06-30
Compliance Officer - 2010-08-31
Manager TitleAgeSince
Director/Board Member 68 2007-02-11
Director/Board Member 67 2008-03-12
Director/Board Member 68 2008-12-31
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-1.04%-3.63%-7.90%-16.23%21.5B
+0.01%-2.67%+10.61%-12.67%201B
-0.15%-2.92%+5.87%-25.27%108B
-1.00%-0.85%-5.29%-10.72%63.61B
-0.10%+3.79%+19.77%+11.32%47.07B
-0.37%-3.24%+20.65%+101.41%47.05B
+0.03%+0.42%+29.56%+28.72%30.42B
-1.52%-0.35%-33.56%-44.96%30.36B
+1.35%-0.98%-5.77%-25.95%23.36B
-0.71%-1.45%+7.68%-6.37%21.31B
Average -0.35%-0.98%+4.16%-0.07% 59.29B
Weighted average by Cap. -0.25%-1.55%+6.86%-3.75%
See all sector performances

Financials

2024 *2025 *
Net sales 7.67B 7.26B 6.73B 6.02B 10.84B 649B 12B 83.71B 30.95B 267B 28.81B 28.17B 1,150B 8.02B 7.59B 7.04B 6.29B 11.34B 679B 12.56B 87.57B 32.37B 279B 30.14B 29.47B 1,203B
Net income 1B 950M 881M 788M 1.42B 85.05B 1.57B 10.96B 4.05B 34.94B 3.77B 3.69B 151B 1.12B 1.06B 982M 879M 1.58B 94.84B 1.75B 12.22B 4.52B 38.97B 4.21B 4.11B 168B
Net Debt 5.12B 4.84B 4.49B 4.01B 7.24B 433B 8.01B 55.86B 20.65B 178B 19.22B 18.8B 767B 3.52B 3.33B 3.09B 2.76B 4.98B 298B 5.51B 38.44B 14.21B 123B 13.23B 12.94B 528B
More financial data * Estimated data
Logo Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc. specializes in designing, manufacturing, and selling orthopedic and dental reconstruction implants, spinal implants, and traumatology products. Net sales break down by family of products as follows: - reconstruction implants (57.5%): knees replacement (58.8% of net sales), hips replacement (41.2%); - surgical products and traumatology equipment (22.1%); - dental, spinal and craniomaxillofacial implants (12.8%); - other (7.6%): primarily orthopedic surgery materials and instruments used during post-operative rehabilitation. At the end of 2021, the group had approximately 30 production sites worldwide. Net sales are distributed geographically as follows: Americas (61.3%), Europe/Middle East/Africa (21.3%) and Asia/Pacific (17.4%).
Employees
18,000
More about the company
Date Price Change Volume
24-12-06 108.03 $ -1.04% 1,141,105
24-12-05 109.16 $ -1.32% 937,755
24-12-04 110.62 $ -0.11% 1,438,163
24-12-03 110.74 $ +0.22% 1,212,778
24-12-02 110.50 $ -1.43% 1,508,746

Delayed Quote Nyse, December 06, 2024 at 04:00 pm EST

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
B
surperformance-ratings-light-chart ZIMMER-BIOMET-HOLDINGS-INMore Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
108.03USD
Average target price
124.65USD
Spread / Average Target
+15.39%
Consensus

Quarterly revenue - Rate of surprise